UVA Center for Diabetes Technology Deploys First AI-Driven Artificial Pancreas
Automated insulin delivery (AID), also known as the artificial pancreas, has revolutionized the management of type 1 diabetes in the past 4 years, driven in large by technologies developed at the University of Virginia. Systems such as the Tandem t:s...
Medicine in Motion News
Phase 1 Clinical Trials
UVA Cancer Center expands access to experimental treatments.
UVA Health Foundation
Researcher Highlight Q&A: Michael E. Williams, MD, Reducing Chemo Harm for Blood Cancer Patients
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
Healthy Practice
UVA Health Researchers Uncover Chemo Drug’s Potential to Treat Heart Failure
A tool created by UVA Health researchers is identifying new treatments for heart failure in drugs approved by the FDA for blood cancer.
Healthy Practice
Lung Transplant Discovery Could Improve Survival Rates
UVA researchers are working to develop processes that could reduce organ rejection and death after lung transplants.
UVA Today